NewsPronto

 
Men's Weekly

.

ACN Newswire

Read more press releases from ACN Newswire here

Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance

  • Written by ACN Newswire

image

SINGAPORE, Jun 24, 2020 - (ACN Newswire) - Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. has announced proven in vitro success with Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing. Impact Biomedical and Global Research and Discovery Group Sciences (GRDG), in...

Read more: Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance